Market Tracker

05/04 11:29am ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

5.25
BATS BZX Real-Time Price
As of 11:26am ET
 -0.19 / -3.49%
Today’s Change
5.14
Today|||52-Week Range
14.50
-39.79%
Year-to-Date

Today’s Trading

Previous close5.44
Today’s open5.47
Day’s range5.25 - 5.47
Volume9,294
Average volume (3 months)796,051
Market cap$287.1M
Dividend yield--
Data as of 11:26am ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-38.89%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book2.31

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc-0.41-4.93%
INFIInfinity Pharmaceuti...-0.39-6.91%
ITEKInotek Pharmaceutica...-0.21-2.04%
IMDZImmune Design Corp-0.70-5.11%
Data as of 11:28am ET, 05/04/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts